News iRhythm digital heart monitoring service backed by NICE A heart monitor developed by iRhythm has become the first product to be endorsed by NICE in a pilot project covering digital health technologies.
News FDA approves first smartphone compatible heart monitor Abbott's first-of-a-kind smartphone compatible heart monitor has been approved by for use in the US.
News Abbott earns CE mark for smartphone-enabled cardiac monitor Abbott’s world’s first smartphone-compatible cardiac monitor capable of remotely monitoring irregular heart rhythms has received CE mark.
News Sandoz separates from Novartis, valued at just over $11bn Sandoz completed its long-heralded separation from Novartis on schedule this morning, with its shares trading at CHF 24 on the SIX Swiss Exchange.
R&D Turning drug development on its head Drug discovery is usually a goal-driven and iterative process, as researchers look for innovative new routes to target particular diseases and study those diseases in afflicted patients to learn ho